Federation Des Caisses Desjardins Du Quebec Oric Pharmaceuticals, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 2,000 shares of ORIC stock, worth $16,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$16,660% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$44 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$40.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$36.6 Million4.67% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$34.5 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$33.3 Million0.16% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $330M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...